6-K
2009 — 20
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
October 12, 2009
 
KONINKLIJKE PHILIPS ELECTRONICS N.V.
(Exact name of registrant as specified in its charter)
Royal Philips Electronics
(Translation of registrant’s name into English)
The Netherlands
(Jurisdiction of incorporation or organization)
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F þ     Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o     No þ
Name and address of person authorized to receive notices
and communications from the Securities and Exchange Commission:
E.P. Coutinho
Koninklijke Philips Electronics N.V.
Amstelplein 2
1096 BC Amsterdam — The Netherlands
 
 

 


 

This report comprises a copy of the Quarterly Report of the Philips Group for the three months ended September 30, 2009, dated October 12, 2009.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized at Amsterdam, on the 12th day of October 2009.
KONINKLIJKE PHILIPS ELECTRONICS N.V.
/s/ E.P. Coutinho
(General Secretary)

 


 

(ROYAL PHILIPS ELECTRONICS LOGO)

(GRAPHIC)
Forward-looking statements
This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items, in particular the paragraphs on “Looking ahead” and “Outlook”. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
These factors include but are not limited to domestic and global economic and business conditions, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips’ actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in our Annual Report 2008 and the “Risk and uncertainties” section in our semi-annual financial report for the six months ended June 28, 2009.
Third-party market share data
Statements regarding market share, including those regarding Philips’ competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.
Use of non-GAAP information
In presenting and discussing the Philips Group’s financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. A reconciliation of such measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in our Annual Report 2008.
Use of fair-value measurements
In presenting the Philips Group’s financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable.
Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When observable market data does not exist, we estimated the fair values using appropriate valuation models. They require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in our 2008 financial statements. Independent valuations may have been obtained to support management’s determination of fair values.
Philips reports third-quarter EBITA of EUR 344 million and sales of EUR 5.6 billion
  Strong improvement of EBITA margin before restructuring and acquisition-related charges and a EUR 87 million provision release
 
  Comparable sales down 11%, mainly attributable to Consumer Lifestyle and Lighting, up from the 19% decline visible in the second quarter
 
  Double-digit growth in emerging markets for Healthcare not fully offsetting declines in the US
 
  Restructuring and acquisition-related charges of EUR 125 million reflect ongoing reduction of our cost base
 
  Free cash flow of EUR 353 million exceeded EBITA in the quarter
    Gerard Kleisterlee,
President and CEO of Royal Philips Electronics:
“Our Q3 results are a reflection of our strong fundamentals and the proactive manner in which we have been managing our costs, allowing us to deliver an underlying profitability of 6.8% of sales in the quarter, among the highest in recent years for the third quarter. We continue to invest in our portfolio of global leading businesses in Healthcare, Consumer Lifestyle and Lighting. We have a strong global brand that is still increasing in strength, climbing one notch to number 42 in the Interbrand top-100 global brand ranking, and we have an increasingly strong presence in emerging markets like India and China which are less affected by the economic downturn.
In addition, the decisive action we took at the end of 2008 to focus on cost and cash management is increasingly becoming visible in our performance. This has led to a set of encouraging results in the third quarter, especially if


     
All amounts in millions of euros unless otherwise stated; data included are unaudited.
Financial reporting is in accordance with IFRS, unless otherwise stated.
This document comprises regulated information within the meaning of the Dutch
Financial Markets Supervision Act ’Wet op het Financieel Toezicht’.
  (PHILIPS LOGO)

 


 

you look at the year-over-year improvement in earnings and cash flow. I would also like to highlight that most businesses across the Company saw further improvement in both comparable sales and underlying earnings compared to the previous quarter, and we are fully focused on continuing this trend in the fourth quarter.
Our continued ability to increase our cash flow by bringing down working capital allowed us to sustain our investments in growth initiatives while maintaining a strong balance sheet. Recent examples are the acquisition of Saeco and our investments in establishing chains of Philips-branded stores for Consumer Lighting in China and India.
We will continue to introduce innovative products in the coming quarter, including a new range of therapy products to better treat sleep apnea patients and new LED-based lighting solutions to light up offices, gardens and retail outlets.
We have been responding to the tough economic environment by stepping up our efforts to make Philips a more customer-focused, agile and simpler company. I believe that our Q3 results show that we are making good progress thanks to the efforts of a committed and engaged global workforce. Therefore, I remain confident that Philips will come out of this recession as a stronger company and a leader in our field.”

2




 

Philips Group

Net income
in millions of euros unless otherwise stated
                 
    Q3   Q3
    2008   2009
 
               
Sales
    6,334       5,621  
 
               
EBITA
    57       344  
as a % of sales
    0.9       6.1  
 
               
EBIT
    (133)      237  
as a % of sales
    (2.1)      4.2  
 
               
Financial income and expenses
    158       (44) 
Income taxes
    3       (56) 
Results equity-accounted investees
    9       39  
Income (loss) from continuing operations
    37       176  
Discontinued operations
    21       -  
Net income (loss) 
    58       176  
 
               
 
               
Attribution of net income (loss)
               
Net income (loss) - stockholders
    57       174  
Net income - minority interests
    1       2  
 
               
 
               
Net income (loss) - stockholders
               
per common share (in euros) - basic
    0.06       0.19  
 
Sales by sector
in millions of euros unless otherwise stated
                                 
    Q3   Q3           % change
    2008   2009   nominal   compa-
                            rable
 
                               
Healthcare
    1,806       1,821       1       (4) 
 
Consumer Lifestyle
    2,578       2,073       (20)      (15) 
 
Lighting
    1,846       1,646       (11)      (13) 
 
GM&S
    104       81       (22)      (24) 
 
Philips Group
    6,334       5,621       (11)      (11) 
Highlights in the quarter
    Net income
   
 
  Income from continuing operations increased by EUR 139 million year-on-year, driven by higher earnings and lower net charges.
 
  Income included a gain of EUR 87 million related to a release of a provision for retiree medical benefits, EUR 125 million of restructuring and acquisition-related charges, and a EUR 30 million partial reversal of last year’s TPV impairment loss.
 
  In Q3 2008, income included a EUR 342 million financial gain on the sale of TSMC shares, which was more than offset by a EUR 259 million asbestos-related settlement charge, EUR 74 million of restructuring and acquisition-related charges, and EUR 189 million in impairment losses at LG Display and Toppoly.
    Sales by sector
   
 
  Sales amounted to EUR 5,621 million, representing a decline of 11% on both a nominal and comparable basis. A positive currency impact of 2% was offset by portfolio changes.
 
  Healthcare sales declined by 4% on a comparable basis, as growth at Customer Services and Home Healthcare Solutions was more than offset by declines at Clinical Care Systems, Imaging Systems and Healthcare Informatics.
 
  Consumer Lifestyle sales fell by 15% on a comparable basis, due to sales declines in all businesses except Health & Wellness.
 
  Lighting sales declined by 13% on a comparable basis, led by double-digit declines at Professional Luminaires, Lighting Electronics and Automotive Lighting.


3


 

Sales per market cluster
in millions of euros unless otherwise stated
                                 
    Q3   Q3             % change
    2008   2009   nominal   compa-
                            rable
                                 
Western Europe
    2,117       1,974       (7)      (6) 
North America
    1,844       1,583       (14)      (16) 
Other mature markets
    311       302       (3)      (9) 
Total mature markets
    4,272       3,859       (10)      (11) 
 
                               
Emerging markets
    2,062       1,762       (15)      (11) 
Philips Group
    6,334       5,621       (11)      (11) 
EBITA
in millions of euros unless otherwise stated
                 
    Q3   Q3
    2008   2009
Healthcare
    188       175  
Consumer Lifestyle
    63       129  
Lighting
    183       79  
Group Management & Services
    (377)      (39) 
Philips Group
    57       344  
as a % of sales
    0.9       6.1  
EBITA
as a % of sales
                 
    Q3   Q3
    2008   2009
Healthcare
    10.4       9.6  
Consumer Lifestyle
    2.4       6.2  
Lighting
    9.9       4.8  
Group Management & Services
    (362.5)      (48.1) 
Philips Group
    0.9       6.1  
Restructuring and acquisition-related charges
in millions of euros
                 
    Q3   Q3
    2008   2009
Healthcare
    (17)      (40) 
Consumer Lifestyle
    (46)      (29) 
Lighting
    (11)      (42) 
Group Management & Services
    -       (14) 
Philips Group
    (74)      (125) 
EBIT
in millions of euros unless otherwise stated
                 
    Q3   Q3
    2008   2009
Healthcare
    129       110  
Consumer Lifestyle
    59       126  
Lighting
    56       40  
Group Management & Services
    (377)      (39) 
Philips Group
    (133)      237  
as a % of sales
    (2.1)      4.2  
   Sales per market cluster
 
  In mature markets, double-digit declines at Lighting and Consumer Lifestyle were partially offset by a mid-single-digit decline at Healthcare.
 
  While sales in the emerging markets showed considerable sequential improvement, they remained 11% below Q3 2008 on a comparable basis. Consumer Lifestyle saw a double-digit sales decline, particularly in Latin America and Russia. While Lighting sales in emerging markets saw a single-digit decline, in China and India they continued to grow. These declines were partially offset by double-digit growth at Healthcare in nearly all emerging markets.
   Earnings
 
  EBITA increased by EUR 287 million compared to Q3 2008, favorably impacted by a EUR 87 million release of a provision for retiree medical benefits and last year’s EUR 259 million asbestos-related charge, partly offset by a EUR 51 million increase in restructuring and acquisition-related charges.
 
  EBIT increased by EUR 370 million compared to Q3 2008, a quarter which also included a goodwill impairment of EUR 90 million at Lumileds.
 
  Healthcare EBITA saw a slight year-on-year decline as Q3 2008 included a EUR 45 million divestment gain. Excluding this gain and restructuring and acquisition-related charges, EBITA improved by EUR 55 million to EUR 215 million (11.8% of sales), thanks to improvements in most businesses, notably Customer Services.
 
  Consumer Lifestyle EBITA was EUR 129 million, or 6.2% of sales, a year-on-year increase of EUR 66 million driven by higher earnings in most businesses. Excluding restructuring and acquisition-related charges, Television was close to break-even, which helped take the overall sector EBITA before charges to EUR 49 million above the level of Q3 2008.
 
  Lighting EBITA was EUR 104 million lower than in Q3 2008 due to lower operational earnings, mainly at Lamps and Professional Luminaires, and higher restructuring and acquisition-related charges. Excluding these charges, EBITA was EUR 73 million lower year-on-year.
 
  GM&S EBITA improved by EUR 338 million compared to Q3 2008, a quarter which included EUR 259 million asbestos-related charges. The current quarter included a EUR 87 million release of a provision for retiree medical benefits.


4


 

Financial income and expenses
in millions of euros
                 
    Q3   Q3
    2008   2009
 
               
Net interest expenses
    (19)      (61) 
 
               
TSMC
               
Sale of securities
    342       -  
Dividend
    23       -  
 
               
LG Display impairment
    (178)      -  
 
               
Toppoly impairment
    (11)      -  
 
               
TPV option fair-value adjustment
    (20)      18  
 
               
Other
    21       (1) 
 
               
 
    158       (44) 
Results relating to equity-accounted investees
in millions of euros
                 
    Q3   Q3
    2008   2009
 
               
TPV value adjustment
    -       30  
 
               
Other
    9       9  
 
               
 
    9       39  
Cash balance
in millions of euros
                 
    Q3    Q3 
    2008    2009 
Cash of continuing operations
    2,396       3,589  
Cash of discontinued operations
    94       -  
Beginning balance
    2,490       3,589  
 
               
Free cash flow
    57       353  
Net cash from operating activities
    210       470  
Net capital expenditures
    (153)      (117) 
Acquisitions (divestments)
    14       (172) 
Other cash from investing activities
    776       (36) 
(Repurchase) delivery of shares
    (803)      6  
Changes in debt/other
    (56)      (6) 
Net cash flow discontinued operations
    (18)      -  
Ending balance
    2,460       3,734  
Less cash of discontinued operations
    -       -  
Cash of continuing operations
    2,460       3,734  
   Financial income and expenses
 
  Net interest expenses increased compared to Q3 2008 as a result of lower interest rates on deposits and higher interest costs on derivatives related to hedging of foreign-currency funding positions.
 
  Q3 2008 included a EUR 342 million gain on the sale of the remaining stake in TSMC as well as dividend income from TSMC of EUR 23 million.
 
  Also in Q3 2008, impairment losses of EUR 178 million and EUR 11 million were reported for LG Display and Toppoly respectively.
   Results relating to equity-accounted investees
 
  A EUR 30 million gain was recorded due to the partial reversal of a EUR 59 million TPV impairment loss recognized in December 2008.
   Cash balance
 
  The Group cash balance increased by EUR 145 million to EUR 3.7 billion, driven by free cash inflow of EUR 353 million, partly offset by EUR 172 million in payments for acquisitions, mainly the Saeco espresso business.
 
  In Q3 2008 the cash balance declined slightly as proceeds from the sale of stakes (EUR 688 million, mainly TSMC), cash from derivatives (EUR 88 million) and free cash inflow (EUR 57 million) were more than offset by share buy-back (EUR 803 million) and short-term debt repayment (EUR 98 million).


5


 

Cash flows from operating activities
 
 in millions of euros
(PERFORMANCE GRAPH)
Gross capital expenditures (PPE*)
 
in millions of euros
(PERFORMANCE GRAPH)
* Capital expenditures on property, plant and equipment only
Inventories as a % of sales *
 
(PERFORMANCE GRAPH)
* Sales is calculated as the sum of the last four quarters
   Cash flows from operating activities
 
  Operating activities generated a cash inflow of EUR 470 million, compared to an inflow of EUR 210 million in Q3 2008. The increase of EUR 260 million was driven by higher cash earnings and lower working capital requirements.
   Gross capital expenditures
 
  Gross capital expenditures on property, plant and equipment were EUR 67 million lower than in Q3 2008, primarily due to lower investments at Lighting and Healthcare.
   Inventories
 
  Inventories as a percentage of sales rose by 0.7 percentage points to 14.0% at the end of the quarter, with modest improvements at Lighting and Healthcare more than offset by an increase at Consumer Lifestyle. The ratio was 1.1 percentage points below the level of Q3 2008, due to lower inventory levels at Healthcare and Lighting.
 
  In value, inventories saw a slight sequential increase as the additional inventory from the acquisition of Saeco was only partly offset by lower inventories at Lighting and Healthcare. Compared to Q3 2008, inventories decreased by EUR 796 million, mainly at Consumer Lifestyle and Lighting.


6


 

Net debt and group equity
 
         
 in billions of euros
  group equity   net debt
(PERFORMANCE GRAPH)
Number of employees (FTEs)
 
(PERFORMANCE GRAPH)
   Net debt and group equity
 
  At the end of the quarter the net debt position amounted to EUR 0.6 billion, compared to EUR 1.5 billion at the end of Q3 2008. During the quarter, the net debt position decreased by EUR 219 million, mainly due to EUR 353 million free cash flow, partly offset by a EUR 169 million cash payment for Saeco.
 
  Group equity remained stable in the quarter at EUR 13.4 billion.
   Employees
 
  The increase in the number of employees was largely attributable to a seasonality-driven increase in temporary labor. The additional headcount related to the acquisition of Saeco was offset by a reduction in permanent employees elsewhere across the Company.
 
  Compared to Q3 2008, the number of employees decreased by 9,786, primarily at Lighting (down 8,431) and Healthcare (down 1,091).


7


 

Healthcare

Key data
in millions of euros unless otherwise stated
                 
    Q3   Q3
    2008   2009
 
               
Sales
    1,806       1,821  
 
               
Sales growth
               
 
               
% nominal
    14       1  
 
               
% comparable
    5       (4) 
 
               
EBITA
    188       175  
 
               
as a % of sales
    10.4       9.6  
 
               
EBIT
    129       110  
 
               
as a % of sales
    7.1       6.0  
 
               
Net operating capital (NOC)
    8,668       8,413  
 
               
Number of employees (FTEs)
    35,841       34,750  
 Sales
 
in millions of euros
(PERFORMANCE GRAPH)
 EBITA
 
EBITA in millions of euros   EBITA as a % of sales
(PERFORMANCE GRAPH)
    Business highlights
 
  Philips acquired InnerCool Therapies Inc., a pioneer in the field of therapeutic hypothermia, strengthening its position in the emergency care market by adding body temperature management solutions.
 
  Philips received certification in China for the latest addition to its value line of ultrasound systems. Designed specifically for emerging markets, this system is part of the HD family of ultrasound systems, which deliver high-quality imaging in an affordable package to meet the needs of both mature and emerging markets.
 
  Egypt’s Ministry of Health and Population is equipping approximately 1,000 ambulances with Philips patient monitoring and defibrillation devices.
 
  Philips, in cooperation with Dutch health insurance firm Achmea, announced that Isala hospitals in the Netherlands have started using the Philips Motiva home healthcare system, marking the ninth installation at a Dutch hospital since the launch of Philips Motiva with Achmea in November 2007.
    Financial performance
 
  Currency-comparable equipment order intake declined 7% year-on-year. The North American market continued to show weakness, mainly affecting Imaging Systems, as the uncertainty around US healthcare reform continued to adversely impact order intake. This decline was partly offset by growth outside North America at Imaging Systems and growth across most businesses in emerging markets.
 
  Comparable sales at Healthcare declined 4% year-on-year. Double-digit growth in emerging markets was offset by declines in the US notably at Imaging Systems, Patient Monitoring and Clinical Care Systems.
 
  EBITA amounted to EUR 215 million, or 11.8% of sales, excluding EUR 40 million of restructuring and acquisition- related charges. The comparable figure in Q3 2008, also excluding a EUR 45 million gain on the sale of Speech Recognition Systems, was EUR 160 million, or 8.9% of sales. EBITA improved at most businesses, notably Customer Services, mainly driven by operational improvement and strict cost management.


8


 

      
    Looking ahead
 
  In Q4, restructuring and acquisition-related charges are expected to total around EUR 35 million.
 
  In October, Philips Respironics will launch a new Sleep Therapy System to treat Obstructive Sleep Apnea. Using intelligent technology, this new system simplifies patient management by immediately indicating the potential need for specialized therapy for OSA patients, and is designed for greater patient comfort by making it easier for patients to adapt to therapy.


9


 

Consumer Lifestyle

Key data
in millions of euros unless otherwise stated
                 
    Q3   Q3
    2008   2009
 
               
Sales
    2,578       2,073  
of which Television
    1,134       767  
 
               
Sales growth
               
% nominal
    (19)      (20) 
% comparable
    (9)      (15) 
 
               
Sales growth excl. Television
               
% nominal
    (16)      (10) 
% comparable
    (7)      (12) 
 
               
EBITA
    63       129  
of which Television
    (73)      (26) 
as a % of sales
    2.4       6.2  
 
               
EBIT
    59       126  
of which Television
    (73)      (26) 
as a % of sales
    2.3       6.1  
 
               
Net operating capital (NOC)
    1,761       1,041  
of which Television
    157       (390) 
 
               
Number of employees (FTEs)
    20,662       19,569  
of which Television
    6,085       5,001  
 Sales
 
     in millions of euros
(PERFORMANCE GRAPH)
 EBITA
 
EBITA in millions of euros   EBITA as a % of sales
(PERFORMANCE GRAPH)
    Business highlights
 
  Philips completed the acquisition of Saeco International Group S.p.A. of Italy, one of the world’s leading espresso machine makers. This move makes Philips a global leader in coffee machines.
 
  Philips showcased its latest consumer-driven innovations at IFA, Europe’s largest consumer lifestyle trade show. Highlights included a new high-end collection of kitchen appliances, a new range of notebook accessories, and the latest TVs and Blu-ray players.
 
  Philips successfully launched Sonicare For Kids, the first-ever Sonicare power toothbrush for children. This step broadens the Philips Oral Healthcare portfolio.
 
  Philips received two product awards from the European Imaging & Sound Association (EISA), with a model in the high-end TV range named “European LCD TV 2009-2010” and the combination of the Philips Cinema 21:9 LCD TV and a Philips Blu-ray Disc player given the “European Home Theater Innovation 2009-2010” award.
    Financial performance
 
  The 20% nominal sales decline includes the impact of proactive portfolio changes, notably at Television and Audio & Video Multimedia. On a comparable basis, sales were 15% below Q3 2008, mainly impacted by double-digit declines at Audio & Video Multimedia, Television, and Peripherals & Accessories. At Domestic Appliances and Shaving & Beauty, sales declines were in the low single-digits, while Health & Wellness showed moderate growth.
 
  EBITA amounted to EUR 129 million, a year-on-year improvement of EUR 66 million. Adjusted for restructuring and acquisition-related charges, EBITA improved from EUR 109 million (4.2% of sales) in Q3 2008 to EUR 158 million (7.6% of sales), with higher earnings in nearly all businesses. Television neared break-even in the quarter due to ongoing improvement actions.
 
  Headcount relative to Q3 2008 showed a slight decrease as the addition of some 2,000 employees following the acquisition of Saeco was more than offset by the effect of portfolio changes and actions taken to rightsize the organization.


10


 

      
     Looking ahead
 
  In Q4, Consumer Lifestyle expects to incur a further EUR 40 million of restructuring charges and EUR 10 million of acquisition-related charges.
 
  Providing Chinese consumers with a new way to easily prepare a variety of healthy meals, Philips will launch an innovative rice cooker in Q4.
 
  Saeco will roll out their latest fully automatic coffee machines, which were very well received at IFA in Berlin. The new flagship Xelsis and the compact Syntia will be available throughout Europe.


     

11


 

Lighting

Key data
in millions of euros unless otherwise stated
                 
    Q3     Q3
    2008     2009
 
               
Sales
    1,846       1,646  
Sales growth
               
% nominal
    19       (11)
% comparable
    6       (13)
 
               
EBITA
    183       79  
as a % of sales
    9.9       4.8  
 
               
EBIT
    56       40  
as a % of sales
    3.0       2.4  
 
               
Net operating capital (NOC)
    6,458       5,382  
 
               
Number of employees (FTEs)
    60,067       51,636  
Sales
 
   in millions of euros
(PERFORMANCE GRAPH)
EBITA
 
EBITA in millions of euros   EBITA as a % of sales
(PERFORMANCE GRAPH)
    Business highlights
   
 
  Philips was the first company to submit an entry in a competition organized by the US Department of Energy challenging the industry to develop high-quality, LED-based alternatives to 60W incandescent light bulbs. The submitted LED retrofit lamp has clear potential to become a mass-market product.
 
  Philips acquired Teletrol Systems Inc., a leading supplier of integrated solutions for simultaneous multi-site management of lighting and energy usage. This acquisition will strengthen Philips’ range of sophisticated control solutions.
 
  Philips achieved further success in energy-efficient LED-based outdoor lighting with new installations of street lighting in 30 towns and cities in Portugal, while also supplying LEDs to light up the prestigious International Garden Festival in France.
 
    Financial performance
   
 
  Comparable sales declined by 13% year-on-year, due to ongoing weakness in many end-markets resulting from the global economic slowdown. Sequentially, however, comparable sales improved in almost all businesses, supported by strong growth in Asian markets.
 
  EBITA amounted to EUR 79 million, or 4.8% of sales. Excluding restructuring and acquisition-related charges, EBITA totaled EUR 121 million, or 7.4% of sales. The comparable figure in Q3 2008 was EUR 194 million, or 10.5% of sales.
 
  Net operating capital decreased by EUR 1.1 billion year-on-year, to EUR 5.4 billion. Working capital requirements declined substantially compared to Q3 2008.
 
    Looking ahead
   
 
  Restructuring and acquisition-related charges of around EUR 85 million are expected in Q4, targeted at further reduction of fixed costs related to conventional lighting technologies.
 
  In Q4, Philips plans to launch a wide range of new LED-based lighting solutions across many segments, including Outdoor, Retail and Office, while continuing to launch LED retrofit lamps in key markets around the world.


12


 

Group Management & Services

Key data
in millions of euros unless otherwise stated
                 
    Q3   Q3
    2008   2009
 
               
Sales
    104       81  
 
               
Sales growth
               
% nominal
    (29)      (22) 
% comparable
    (24)      (24) 
 
               
EBITA Corporate Technologies
    (26)      (45) 
EBITA Corporate & Regional Costs
    (55)      (44) 
EBITA Pensions
    1       76  
EBITA Service Units and Other
    (297)      (26) 
 
               
EBITA
    (377)      (39) 
EBIT
    (377)      (39) 
 
               
Net operating capital (NOC)
    484       (3,277) 
Number of employees (FTEs)
    11,441       12,270  
Sales
 
   in millions of euros
(PERFORMANCE GRAPH)
EBITA
 
   in millions of euros
(PERFORMANCE GRAPH)
    Business highlights
   
 
  Philips improved its position in the annual top-100 global brands ranking from Interbrand, moving up one notch to become the 42nd most valuable brand in the world with a total brand value of USD 8.1 billion.
 
  For the 9th year in a row Philips was included in the Dow Jones Sustainability Indexes, which track the sustainability performance of the world’s largest companies, receiving sector leadership status in the category Leisure Goods.
 
  Philips Research continues to join forces to foster innovation in healthcare, partnering with Bruker BioSpin to develop ground-breaking Magnetic Particle Imaging technology for the preclinical market, and with GlyGenix Therapeutics to explore the use of ultrasound technologies in gene therapy.
 
  Philips Design received several design awards including the prestigious INDEX:Award for its innovative, sustainable healthy cooking stove Chulha and a Bronze Industrial Design Excellence Award for the Philips Kitten Scanner.
 
    Financial performance
   
 
  EBITA amounted to a loss of EUR 39 million, compared to a loss of EUR 377 million in Q3 2008. The year-on-year improvement was driven by a EUR 87 million release of a provision for retiree medical benefits, whereas Q3 2008 included a EUR 259 million asbestos-related charge. Restructuring charges amounted to EUR 14 million.
 
  Net operating capital decreased by EUR 3.8 billion year-on-year, due to pension adjustments in Q4 2008 and Q2 2009.
 
    Looking ahead
   
 
  Restructuring charges at Group Management & Services are expected to amount to EUR 30 million in Q4, largely related to the realignment of group R&D activities.


13


 

Highlights in the 1st nine months

The 1st nine months of 2009
  Comparable sales were 16% lower than in the first nine months of 2008, reflecting the impact of the global economic downturn, with declines visible in all sectors, mainly at Consumer Lifestyle (23%) and Lighting (17%).
 
  EBITA amounted to EUR 388 million, 46% lower than in the corresponding period of 2008, primarily due to higher restructuring and acquisition-related charges, offset by a release of a provision for retiree medical benefits; Q3 2008 included the asbestos settlement and net gains on the sale of businesses and real estate.
 
  Compared to the first nine months of 2008, financial income and expenses declined by EUR 0.9 billion to a net expense of EUR 88 million, mainly due to last year’s gains on the sale of stakes in TSMC (EUR 1.2 billion) and LG Display (EUR 158 million), higher impairment charges for NXP (EUR 251 million) and impairment charges for LG Display (EUR 178 million) and Toppoly (EUR 42 million).
 
  Results relating to equity-accounted investees included the TPV value adjustment (EUR 55 million), whereas last year’s figure was mainly comprised of operational earnings of LG Display (EUR 66 million).
Net income

in millions of euros unless otherwise stated
                 
    January-September  
    2008     2009  
 
               
Sales
    18,762       15,926  
 
               
EBITA
    718       388  
as a % of sales
    3.8       2.4  
 
               
EBIT
    357       59  
as a % of sales
    1.9       0.4  
 
               
Financial income and expenses
    793       (88) 
Income tax expense
    (139)      130  
Results equity-accounted investees
    71       63  
Income (loss) from continuing operations
    1,082       164  
Discontinued operations
    5       -  
Net income (loss)
    1,087       164  
 
               
Attribution of net income (loss)
               
Net income (loss) - stockholders
    1,083       159  
Net income - minority interests
    4       5  
 
               
Net income (loss) - stockholders
               
Per common share (in euros) - basic
    1.07       0.17  
   Management summary
 
  Sales for the first nine months totaled EUR 15.9 billion, 16% lower than in the corresponding period of 2008 on a comparable basis. The year-to-date share of total sales attributable to emerging markets was 29%, 2 percentage points below last year. Order intake at Healthcare declined 11% compared to the first nine months of 2008. Sales at Healthcare showed a comparable decline of 4% year-on-year, while comparable sales at Consumer Lifestyle declined 23%. Lighting showed a 17% comparable decrease year-on-year.
 
  EBITA in the first nine months of 2009 was EUR 388 million, 46% lower than in the corresponding period of 2008. EBITA includes a release of a provision for retiree medical benefits (EUR 87 million) and higher restructuring and acquisition-related charges (EUR 87 million), whereas last year included EUR 259 million of charges related to the asbestos claim settlement, gains on the sale of the Set-Top Box business (EUR 40 million), the Speech Recognition activity (EUR 45 million) and real estate (EUR 39 million), as well as a loss on the sale of HTP Optics (EUR 13 million).
 
  Net income in the first nine months of 2009 decreased by EUR 0.9 billion compared to the corresponding period of 2008. This reduction is attributable to EUR 298 million lower EBIT and a EUR 0.9 billion decline in financial income, offset by lower income tax expense (EUR 269 million) mainly due to recognition of a deferred tax asset for Lumileds and a number of tax settlements.
 
  Cash flows from operating activities showed an increase of EUR 723 million compared to the first nine months of 2008, resulting from strict management of working capital (in particular inventory levels).
 
  Net operating capital decreased by EUR 5.8 billion compared to the level at the end of Q3 2008, largely due to lower working capital requirements (EUR 5.0 billion), including adjustments to pension assets and liabilities (EUR 3.5 billion).


14


 

Other information
 

  Other information
 
Asbestos
In the third quarter, the opposition filed against TH Agriculture & Nutrition’s (THAN) plan of reorganization (the Plan) has been successfully resolved. Provided that there will be no further opposition to the Plan, it is expected that the US District Court will affirm the Plan in the coming weeks, in which case the Plan would become effective in the fourth quarter, triggering THAN and Philips Electronics North America Corporation’s obligation to fund an asbestos personal injury trust with USD 900 million (around EUR 600 million). Philips has already provided for this amount.
For more information on remaining contingent liabilities, please refer to previous disclosure in our annual and semi-annual reports.


15


 

Outlook

  Outlook
 
While encouraged by the positive development in sales and profitability during the third quarter, we remain cautious about the short-term outlook in the absence of structural recovery in the majority of our end-markets.
Consequently, we will continue to focus on managing costs and cash flow while progressing with actions to capitalize on future economic growth. These actions include maintaining investments in innovation and marketing, as well as making further investments in our product offering and our organizational footprint, particularly in emerging markets.
We are confident that this approach will deliver a sustained improvement in our performance, augmented by the impact of sales recovery when it comes.
Amsterdam, October 12, 2009
Board of Management


16


 

Consolidated statements of income
all amounts in millions of euros unless otherwise stated
                                 
    3rd quarter      January to September  
    2008     2009      2008     2009  
 
 
                               
Sales
    6,334       5,621       18,762       15,926  
 
                               
Cost of sales
    (4,422 )     (3,645 )     (12,720 )     (10,518 )
 
Gross margin
    1,912       1,976       6,042       5,408  
 
                               
Selling expenses
    (1,304 )     (1,242 )     (3,730 )     (3,640 )
 
                               
General and administrative expenses
    (280 )     (129 )     (763 )     (597 )
 
                               
Research and development expenses
    (444 )     (372 )     (1,250 )     (1,161 )
 
                               
Impairment of goodwill
    (90 )     -       (90 )     -  
 
                               
Other business income
    97       9       224       73  
 
                               
Other business expenses
    (24 )     (5 )     (76 )     (24 )
 
                               
 
Income (loss) from operations
    (133 )     237       357       59  
 
                               
Financial income
    421       35       1,566       208  
 
                               
Financial expenses
    (263 )     (79 )     (773 )     (296 )
 
                               
 
Income (loss) before taxes
    25       193       1,150       (29 )
 
                               
Income taxes
    3       (56 )     (139 )     130  
 
                               
 
Income after taxes
    28       137       1,011       101  
 
                               
Results relating to equity-accounted investees
    9       39       71       63  
 
                               
 
Income from continuing operations
    37       176       1,082       164  
 
                               
Discontinued operations - net of income taxes
    21       -       5       -  
 
                               
 
Net income for the period
    58       176       1,087       164  
 
                               
Attribution of net income for the period
                               
 
                               
Net income attributable to stockholders
    57       174       1,083       159  
 
                               
Net loss attributable to minority interests
    1       2       4       5  
 
                               
Weighted average number of common shares outstanding (after deduction
                               
 
                               
of treasury stock) during the period (in thousands):
                               
 
                               
basic
    972,087       926,461       1,010,707       925,001  
 
                               
diluted
    977,701       930,512       1,018,530       927,889  
 
                               
Net income attributable to stockholders
                               
 
                               
per common share in euros:
                               
 
                               
basic
    0.06       0.19       1.07       0.17  
 
                               
diluted
    0.06       0.19       1.06       0.17  
 
                               
Ratios
                               
 
                               
Gross margin as a % of sales
    30.2       35.2       32.2       34.0  
 
                               
Selling expenses as a % of sales
    (20.6 )     (22.1 )     (19.9 )     (22.9 )
 
                               
G&A expenses as a % of sales
    (4.4 )     (2.3 )     (4.1 )     (3.7 )
 
                               
R&D expenses as a % of sales
    (7.0 )     (6.6 )     (6.7 )     (7.3 )
 
                               
EBIT or Income (loss) from operations
    (133 )     237       357       59  
 
                               
as a % of sales
    (2.1 )     4.2       1.9       0.4  
 
                               
EBITA
    57       344       718       388  
 
                               
as a % of sales
    0.9       6.1       3.8       2.4  
 
                               

17


 

Consolidated balance sheets
in millions of euros unless otherwise stated
                         
    September 28,     December 31,     September 27,  
    2008     2008     2009  
 
                       
Current assets:
                       
 
                       
Cash and cash equivalents
    2,460       3,620       3,734  
 
                       
Receivables
    5,015       4,289       4,214  
 
                       
Inventories
    4,092       3,371       3,296  
 
                       
Other current assets
    654       749       689  
 
                       
Total current assets
    12,221       12,029       11,933  
 
                       
Non-current assets:
                       
 
                       
Investments in equity-accounted investees
    321       293       270  
 
                       
Other non-current financial assets
    1,971       1,331       850  
 
                       
Non-current receivables
    52       47       84  
 
                       
Other non-current assets
    2,849       1,906       137  
 
                       
Deferred tax assets
    747       931       1,368  
 
                       
Property, plant and equipment
    3,499       3,496       3,326  
 
                       
Intangible assets excluding goodwill
    4,591       4,477       4,165  
 
                       
Goodwill
    7,321       7,280       7,242  
 
                       
Total assets
    33,572       31,790       29,375  
 
                       
Current liabilities:
                       
 
                       
Accounts and notes payable
    3,171       2,992       3,044  
 
                       
Accrued liabilities
    3,260       3,634       3,070  
 
                       
Short-term provisions
    957       1,043       1,187  
 
                       
Other current liabilities
    435       522       628  
 
                       
Short-term debt
    664       722       757  
 
                       
Total current liabilities
    8,487       8,913       8,686  
 
                       
Non-current liabilities:
                       
 
                       
Long-term debt
    3,324       3,466       3,598  
 
                       
Long-term provisions
    1,809       1,794       1,747  
 
                       
Deferred tax liabilities
    904       584       150  
 
                       
Other non-current liabilities
    995       1,440       1,796  
 
                       
Total liabilities
    15,519       16,197       15,977  
 
                       
Minority interests
    53       49       53  
 
                       
Stockholders’ equity
    18,000       15,544       13,345  
 
                       
Total liabilities and equity
    33,572       31,790       29,375  
 
                       
Number of common shares outstanding (after deduction of treasury stock)
                       
 
                       
at the end of period (in thousands)
    946,366       922,982       926,687  
 
                       
Ratios
                       
 
                       
Stockholders’ equity per common share in euros
    19.02       16.84       14.40  
 
                       
Inventories as a % of sales
    15.1       12.8       14.0  
 
                       
Net debt : group equity
    8:92       4:96       4:96  
 
                       
Net operating capital
    17,371       14,069       11,559  
 
                       
Employees at end of period
    128,011       121,398       118,225  
 
                       

18


 

Consolidated statements of cash flows
all amounts in millions of euros unless otherwise stated
                                 
    3rd quarter      January to September  
    2008     2009      2008     2009  
 
                               
Cash flows from operating activities:
                               
 
                               
Net income attributable to stockholders
    57       174       1,083       159  
 
                               
Loss discontinued operations
    (21 )     -       (5 )     -  
 
                               
Minority interests
    1       2       4       5  
 
                               
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
                               
 
                               
Depreciation and amortization
    373       362       994       1,040  
 
                               
Impairment of goodwill and (reversal of) impairment of equity-accounted investees and other non-current financial assets
    309       (28 )     608       (4 )
 
                               
Net gain on sale of assets
    (459 )     (3 )     (1,569 )     (127 )
 
                               
Income from equity-accounted investees
    (7 )     (10 )     (78 )     (11 )
 
                               
Dividends received from equity-accounted investees
    3       -       63       34  
 
                               
(Increase) decrease in working capital:
    (143 )     194       (1,334 )     98  
 
                               
(Increase) decrease in receivables and other current assets
    (168 )     (490 )     (412 )     131  
 
                               
(Increase) decrease in inventories
    (244 )     (76 )     (684 )     148  
 
                               
Increase (decrease) in accounts payable, accrued and other liabilities
    269       760       (238 )     (181 )
 
                               
Increase in non-current receivables/other assets/ other liabilities
    (219 )     (111 )     (252 )     (513 )
 
                               
Increase (decrease) in provisions
    339       (124 )     290       (99 )
 
                               
Other items
    (23 )     14       83       28  
 
                               
 
Net cash provided by (used for) operating activities
    210       470       (113 )     610  
 
                               
Cash flows from investing activities:
                               
 
                               
Purchase of intangible assets
    (23 )     (21 )     (87 )     (66 )
 
                               
Expenditures on development assets
    (27 )     (43 )     (137 )     (129 )
 
                               
Capital expenditures on property, plant and equipment
    (188 )     (121 )     (514 )     (373 )
 
                               
Proceeds from disposals of property, plant and equipment
    85       68       157       95  
 
                               
Cash from (to) derivatives
    88       (28 )     343       (38 )
 
                               
Purchase of other non-current financial assets
    -       -       -       (6 )
 
                               
Proceeds from (disposal of) other non-current financial assets
    688       (8 )     2,576       698  
 
                               
Purchase of businesses, net of cash acquired
    (26 )     (191 )     (5,293 )     (281 )
 
                               
Proceeds from sale of interests in businesses
    40       19       40       19  
 
                               
 
Net cash provided by (used for) investing activities
    637       (325 )     (2,915 )     (81 )
 
                               
Cash flows from financing activities:
                               
 
                               
(Decrease) increase in short-term debt
    (98 )     45       (96 )     (53 )
 
                               
Principal payments on long-term debt
    (9 )     (11 )     (1,715 )     (35 )
 
                               
Proceeds from issuance of long-term debt
    10       11       2,077       300  
 
                               
Treasury stock transactions
    (803 )     6       (2,886 )     21  
 
                               
Dividend paid
    -       -       (698 )     (634 )
 
                               
 
Net cash used for financing activities
    (900 )     51       (3,318 )     (401 )
 
                               
Net cash used for continuing operations
    (53 )     196       (6,346 )     128  
 
                               
Cash flows from discontinued operations:
                               
 
                               
Net cash used for operating activities
    (18 )     -       (50 )     -  
 
                               
Net cash used for investing activities
    -       -       (1 )     -  
 
                               
 
Net cash used for discontinued operations
    (18 )     -       (51 )     -  
 
                               
Net cash used for continuing and discontinued operations
    (71 )     196       (6,397 )     128  
 
                               
Effect of change in exchange rates on cash positions
    41       (51 )     (20 )     (14 )
 
                               
Cash and cash equivalents at beginning of period
    2,490       3,589       8,877       3,620  
 
                               
Cash and cash equivalents at end of period
    2,460       3,734       2,460       3,734  
 
                               
 
Cash of continuing operations at end of period
    2,460       3,734       2,460       3,734  
 
                               
For a number of reasons, principally the effects of translation differences, certain items in the statements of cash flows do not correspond to the differences between
the balance sheet amounts for the respective items.
       
 
                               
Ratio
                               
Cash flows before financing activities
    847       145       (3,028 )     529  
 
                               
Net cash paid during the period for
                               
 
                               
- Pensions
    (90 )     (111 )     (266 )     (315 )
 
                               
- Interest
    (39 )     (76 )     (117 )     (212 )
 
                               
- Income taxes
    (71 )     (64 )     (279 )     (172 )
 
                               

19


 

     
                                                                                                 
Consolidated statements of changes in equity  
all amounts in millions of euros
 
   
January to September 2009
                                  other reserves                        
 
                                    currency     unrealized gain (loss)     changes in             treasury     total              
 
    common     capital in excess     retained     revaluation     translation     on available-for-     fair value of             shares at     stockholders’     minority     total  
 
    stock     of par value     earnings     reserve     differences     sale securities     cash flow hedges     total     cost     equity     interests     equity  
 
                                                                                               
 
Balance as of December 31, 2008
    194       -         17,101         117         (527)       (25)       (28)       (580)       (1,288)       15,544         49         15,593    
 
                                                                                               
Net income
                    159                                         -                 159         5         164    
 
Net current period change
                    (1,761)       (11)       (152)       222         (27)       43                 (1,729)       (1)       (1,730)  
 
Reclassifications into (income) loss
                                            (123)       71         (52)               (52)               (52)  
 
Total comprehensive income
                    (1,602)       (11)       (152)       99         44         (9)               (1,622)       4         (1,618)  
 
                                                                                               
Dividend distributed
                    (647)                                                       (647)               (647)  
 
Re-issuance of treasury stock
            (49)       (16)                                               86         21                 21    
 
Share-based compensation plans
            49                                                                 49                 49    
 
 
            -         (663)                                               86         (577)               (577)  
 
                                                                                               
 
Balance as of September 27, 2009
    194       -         14,836         106         (679)       74         16         (589)       (1,202)       13,345         53         13,398    

20


 

Sectors
all amounts in millions of euros unless otherwise stated
                                                 
 
Sales and income (loss) from operations
 
   
3rd quarter    
  2008     2009 
    sales     income from operations   sales     income from operations 
            amount     as % of           amount     as % of 
                    sales                   sales 
 
                                               
Healthcare
    1,806       129       7.1       1,821       110       6.0  
 
Consumer Lifestyle *
    2,578       59       2.3       2,073       126       6.1  
 
Lighting
    1,846       56       3.0       1,646       40       2.4  
 
Group Management & Services
    104       (377 )     (362.5 )     81       (39 )     (48.1 )
 
 
    6,334       (133 )     (2.1 )     5,621       237       4.2  
 
                                               
* of which Television
    1,134       (73 )     (6.4 )     767       (26 )     (3.4 )
 
                                                 
  January to September
   
  2008     2009 
    sales     income from operations   sales     income from operations 
            amount     as % of           amount     as % of 
                    sales                   sales 
 
 
                                               
Healthcare
    5,080       342       6.7       5,434       199       3.7  
 
Consumer Lifestyle *
    7,900       150       1.9       5,564       61       1.1  
 
Lighting
    5,423       400       7.4       4,700       (57 )     (1.2 )
 
Group Management & Services
    359       (535 )     (149.0 )     228       (144 )     (63.2 )
 
 
    18,762       357       1.9       15,926       59       0.4  
 
                                               
* of which Television
    3,593       (283 )     (7.9 )     2,037       (208 )     (10.2 )
 

21


 

Sectors and main countries
all amounts in millions of euros
                                 
Sales and total assets  
 
   
sales
    total assets  
    January to September     Sept 28,     Sept 27,  
    2008     2009     2008     2009  
   
 
                               
Healthcare
    5,080       5,434       11,074       10,826  
 
Consumer Lifestyle
    7,900       5,564       4,698       3,823  
 
Lighting
    5,423       4,700       7,915       6,874  
 
Group Management & Services
    359       228       9,885       7,852  
 
    18,762       15,926       33,572       29,375  
 









                               
Sales and long-lived assets  
 
   
sales
    long-lived assets *  
    January to September     Sept 28,     Sept 27,  
    2008     2009     2008     2009  
   
 
                               
United States
    5,001       4,499       10,781       9,527  
 
Germany
    1,407       1,305       310       292  
 
China
    1,277       1,222       233       336  
 
France
    1,161       977       129       125  
 
United Kingdom
    767       495       633       580  
 
Netherlands
    713       598       1,351       1,251  
 
Other countries
    8,436       6,830       1,974       2,622  
 
    18,762       15,926       15,411       14,733  
* Includes property, plant and equipment, intangible assets and goodwill

22


 

Pension costs
all amounts in millions of euros
                                                 
Specification of pension costs  
    3rd quarter  
    2008     2009  
    Netherlands     other     total     Netherlands     other     total  
 
                                               
Costs of defined-benefit plans (pensions)
                                               
 
                                               
Service cost
    33       19       52       26       17       43  
Interest cost on the defined-benefit obligation
    131       100       231       133       95       228  
Expected return on plan assets
    (193 )     (98 )     (291 )     (190 )     (83 )     (273 )
Prior service cost
    -       5       5       -       1       1  
Net periodic cost (income)
    (29 )     26       (3 )     (31 )     30       (1 )
 
                                               
Costs of defined-contribution plans
                                               
 
                                               
Costs
    3       22       25       3       24       27  
Total
    3       22       25       3       24       27  
 
                                               
Costs of defined-benefit plans (retiree medical)
                                               
 
                                               
Service cost
    -       1       1       -       -       -  
Interest cost on the defined-benefit obligation
    -       9       9       -       9       9  
Prior service cost
    -       (8 )     (8 )     -       -       -  
Curtailment
    -       -       -       -       (87 )     (87 )
Net periodic cost
    -       2       2       -       (78 )     (78 )
                                                 
    January to September  
    2008     2009  
    Netherlands     other     total     Netherlands     other     total  
 
                                               
Costs of defined-benefit plans (pensions)
                                               
 
                                               
Service cost
    101       63       164       80       61       141  
Interest cost on the defined-benefit obligation
    393       297       690       399       296       695  
Expected return on plan assets
    (577 )     (294 )     (871 )     (569 )     (256 )     (825 )
Prior service cost
    -       10       10       -       3       3  
Net periodic cost (income)
    (83 )     76       (7 )     (90 )     104       14  
 
                                               
Costs of defined-contribution plans
                                               
 
                                               
Costs
    5       68       73       6       77       83  
Total
    5       68       73       6       77       83  
 
                                               
Costs of defined-benefit plans (retiree medical)
                                               
 
                                               
Service cost
    -       3       3       -       1       1  
Interest cost on the defined-benefit obligation
    -       26       26       -       27       27  
Prior service cost
    -       (6 )     (6 )     -       -       -  
Curtailment
    -       -       -       -       (87 )     (87 )
Net periodic cost
    -       23       23       -       (59 )     (59 )

23


 

Reconciliation of non-GAAP performance measures
all amounts in millions of euros unless otherwise stated
Certain non-GAAP financial measures are presented when discussing the Philips Group’s performance. In the following tables, a reconciliation to the most directly comparable IFRS performance measure is made.
                                                                 
Sales growth composition (in %)  
    3rd quarter     January to September  
    com-             consol-             com-             consol-        
    parable     currency     idation     nominal     parable     currency     idation     nominal  
    growth     effects     changes     growth     growth     effects     changes     growth  
 
                                                               
2009 versus 2008
                                                               
Healthcare
    (3.8 )     4.8       (0.2 )     0.8       (3.5 )     6.6       3.9       7.0  
Consumer Lifestyle
    (14.6 )     (0.5 )     (4.5 )     (19.6 )     (23.3 )     -       (6.3 )     (29.6 )
Lighting
    (13.0 )     1.6       0.6       (10.8 )     (16.6 )     2.5       0.8       (13.3 )
GM&S
    (23.6 )     1.6       (0.1 )     (22.1 )     (36.6 )     0.2       (0.1 )     (36.5 )
Philips Group
    (10.9 )     1.5       (1.9 )     (11.3 )     (15.7 )     2.4       (1.8 )     (15.1 )
                                         
EBITA to Income from operations (or EBIT)  
    Philips     Consumer        
    Group     Healthcare     Lifestyle     Lighting     GM&S  
 
                                       
January to September 2009
                                       
EBITA
    388       396       73       63       (144 )
Amortization of intangibles *
    (329 )     (197 )     (12 )     (120 )     -  
Income from operations (or EBIT)
    59       199       61       (57 )     (144 )
                                         
January to September 2008
                                       
EBITA
    718       496       162       595       (535 )
Amortization of intangibles *
    (271 )     (154 )     (12 )     (105 )     -  
Impairment of goodwill
    (90 )     -       -       (90 )     -  
Income from operations (or EBIT)
    357       342       150       400       (535 )
* Excluding amortization of software and product development
                 
Composition of net debt and group equity  
    Sept 28,     Sept 27,  
    2008     2009  
Long-term debt
    3,324       3,598  
Short-term debt
    664       757  
Total debt
    3,988       4,355  
Cash and cash equivalents
    2,460       3,734  
Net debt (total debt less cash and cash equivalents)
    1,528       621  
 
               
Minority interests
    53       53  
Stockholders’ equity
    18,000       13,345  
Group equity
    18,053       13,398  
 
               
Net debt and group equity
    19,581       14,019  
 
               
Net debt divided by net debt and group equity (in %)
    8       4  
Group equity divided by net debt and group equity (in %)
    92       96  
 
               

24


 

Reconciliation of non-GAAP performance measures
     (continued)
all amounts in millions of euros unless otherwise stated
                                         
Net operating capital to total assets
                    Consumer              
    Philips Group     Healthcare     Lifestyle     Lighting     GM&S  
 
                                       
September 27, 2009
                                       
Net operating capital (NOC)
    11,559       8,413       1,041       5,382       (3,277 )
Exclude liabilities comprised in NOC:
                                       
- payables/liabilities
    8,538       1,995       2,347       1,130       3,066  
- intercompany accounts
    -       33       78       48       (159 )
- provisions
    2,934       312       356       301       1,965  
Include assets not comprised in NOC:
                                       
- investments in equity-accounted investees
    270       73       1       13       183  
- other current financial assets
    122       -       -       -       122  
- other non-current financial assets
    850       -       -       -       850  
- deferred tax assets
    1,368       -       -       -       1,368  
- liquid assets
    3,734       -       -       -       3,734  
Total assets
    29,375       10,826       3,823       6,874       7,852  
                                         
September 28, 2008
                                       
Net operating capital (NOC)
    17,371       8,668       1,761       6,458       484  
Exclude liabilities comprised in NOC:
                                       
- payables/liabilities
    7,861       2,050       2,571       1,253       1,987  
- intercompany accounts
    -       40       96       30       (166 )
- provisions
    2,766       259       268       160       2,079  
Include assets not comprised in NOC:
                                       
- investments in equity-accounted investees
    321       57       2       14       248  
- other current financial assets
    75       -       -       -       75  
- other non-current financial assets
    1,971       -       -       -       1,971  
- deferred tax assets
    747       -       -       -       747  
- liquid assets
    2,460       -       -       -       2,460  
Total assets
    33,572       11,074       4,698       7,915       9,885  
                                 
Composition of cash flows - continuing operations  
    3rd quarter     January to September  
    2008     2009     2008     2009  
 
                               
Cash flows provided by (used for) operating activities
    210       470       (113 )     610  
Cash flows provided by (used for) investing activities
    637       (325 )     (2,915 )     (81 )
Cash flows before financing activities
    847       145       (3,028 )     529  
 
                               
Cash flows provided by (used for) operating activities
    210       470       (113 )     610  
Net capital expenditures
    (153 )     (117 )     (581 )     (473 )
Free cash flows
    57       353       (694 )     137  

25


 

Philips quarterly statistics
all amounts in millions of euros unless otherwise stated
                                                                 
 
    2008     2009  
    1st     2nd     3rd     4th     1st     2nd     3rd     4th  
    quarter     quarter     quarter     quarter     quarter     quarter     quarter     quarter  
 
                                                               
Sales
    5,965       6,463       6,334       7,623       5,075       5,230       5,621          
% increase
    1       7       (2 )     (9 )     (15 )     (19 )     (11 )        
 
                                                               
EBITA
    265       396       57       26       (74 )     118       344          
as a % of sales
    4.4       6.1       0.9       0.3       (1.5 )     2.3       6.1          
 
                                                               
EBIT
    187       303       (133 )     (303 )     (186 )     8       237          
as a % of sales
    3.1       4.7       (2.1 )     (4.0 )     (3.7 )     0.2       4.2          
 
                                                               
Net income (loss) - stockholders
    294       732       57       (1,174 )     (59 )     44       174          
per common share in euros
    0.28       0.72       0.06       (1.26 )     (0.06 )     0.05       0.19          
                                                                 
    January-     January-     January-     January-     January-     January-     January-     January-  
    March     June     September     December     March     June     September     December  
 
                                                               
Sales
    5,965       12,428       18,762       26,385       5,075       10,305       15,926          
% increase
    1       4       2       (2 )     (15 )     (17 )     (15 )        
 
                                                               
EBITA
    265       661       718       744       (74 )     44       388          
as a % of sales
    4.4       5.3       3.8       2.8       (1.5 )     0.4       2.4          
 
                                                               
EBIT
    187       490       357       54       (186 )     (178 )     59          
as a % of sales
    3.1       3.9       1.9       0.2       (3.7 )     (1.7 )     0.4          
 
                                                               
Net income (loss) - stockholders
    294       1,026       1,083       (91 )     (59 )     (15 )     159          
per common share in euros
    0.28       1.00       1.07       (0.09 )     (0.06 )     (0.02 )     0.17          
 
                                                               
Net income (loss) from continuing
                                                               
operations as a % of
                                                               
stockholders’ equity (ROE)
    6.2       10.8       7.8       (0.5 )     (1.7 )     (0.2 )     1.5          
 
                                                               
    period ended 2008
  period ended 2009
 
                                                               
Inventories as a % of sales
    13.6       13.9       15.1       12.8       13.1       13.3       14.0          
 
                                                               
Net debt : group equity ratio
    4:96       7:93       8:92       4:96       3:97       6:94       4:96          
 
                                                               
Total employees (in thousands)
    134       133       128       121       116       116       118          
of which discontinued operations
    6       5       -       -       -       -       -          
 
                                                               
Information also available on Internet, address:

www.investor.philips.com Printed in the Netherlands

26